Warning! The directory is not yet complete and will be amended until the beginning of the term.
270226 VO Pharmaceutical and solution chemistry of (metallo)drugs (2021W)
Labels
ON-SITE
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: English
Examination dates
Lecturers
Classes (iCal) - next class is marked with N
1.11.-30.11.2021
- Wednesday 03.11. 11:00 - 12:30 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
- Thursday 04.11. 12:30 - 14:00 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
- Monday 08.11. 14:00 - 15:30 Hörsaal 4 Chemie HP Währinger Straße 42
- Tuesday 09.11. 16:30 - 18:00 Kleiner Hörsaal 3 Chemie Boltzmanngasse 1 HP
- Wednesday 10.11. 11:00 - 12:30 Seminarraum 2 Währinger Straße 38 Dekanat 1. Stock
- Thursday 11.11. 09:00 - 10:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
- Tuesday 16.11. 16:30 - 18:00 Kleiner Hörsaal 3 Chemie Boltzmanngasse 1 HP
- Wednesday 17.11. 10:00 - 11:30 Hörsaal 4 Chemie HP Währinger Straße 42
- Thursday 18.11. 09:00 - 10:30 Seminarraum 3 Organische Chemie 1OG Boltzmanngasse 1
Information
Aims, contents and method of the course
Assessment and permitted materials
Minimum requirements and assessment criteria
Examination topics
Reading list
Medicinal Chemistry: Principles and Practice (Ed. F.D. King), Royal Society of Chemistry, 2002.; M.T. Beck; I. Nagypál; Chemistry of Complex Equilibria, Ellis Horwood, Chichester, UK, 1990; Metallotherapeutic Drugs and Metal-based Diagnostic Agents (Eds, M. Gielen, E.R.T. Tiekink), Wiley, Chichester, 2005.
Association in the course directory
EF-1, EF-2, EF-3
Last modified: Tu 21.12.2021 11:07
Factors affecting pharmacokinetics (LADME properties: liberation, absorption, distribution, metabolism, excretion), bioavailability, accumulation, biofluids; routes of drug administration. Acid-base properties: macroconstants and microscopic proton dissociation constants. Lipophilicity, solubility and their modifications. Experimental determination of pKa and logP values. Biological pH-buffers.
Metal containing drugs (anticancer/-bacterial/-diabetic; chelate therapy). Solution stability of metal complexes, complex formation equilibrium processes. Conditional stability constants. Concentration distribution. Experimental determination of stability constants. Lipophilicity of metal complexes. Redox properties of metal complexes.
Prodrugs (metallic, nonmetallic).
Effect of interaction with biological macromolecules (proteins, DNA) on pharmacokinetics. Plasma protein binding. Experimental determination of binding sites and binding constants of protein-ligand adducts.